| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/1997 | WO1997002249A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | WO1996041877A3 Malarial pre-erythrocytic stage polypeptide molecules |
| 01/23/1997 | WO1996040945A3 Nucleic acid respiratory syncytial virus vaccines |
| 01/23/1997 | WO1996040940A3 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 01/23/1997 | WO1996040918A3 Novel cd40l mutein |
| 01/23/1997 | WO1996038558A3 A human purinergic p2u receptor |
| 01/23/1997 | CA2226121A1 Parevins and tachytegrins |
| 01/23/1997 | CA2225824A1 Breast specific genes and proteins |
| 01/23/1997 | CA2225616A1 Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases |
| 01/23/1997 | CA2224715A1 Macrolides |
| 01/23/1997 | CA2222722A1 Novel human chromosome 16 genes, compositions, methods of making and using same |
| 01/23/1997 | CA2198729A1 A novel human map kinase homolog |
| 01/22/1997 | EP0754754A1 Fk506-binding protein gene |
| 01/22/1997 | EP0754752A2 Dipeptidyl peptidase IV and process for producing the same |
| 01/22/1997 | EP0754751A1 Novel deoxyribonuclease |
| 01/22/1997 | EP0754703A1 Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain |
| 01/22/1997 | EP0754231A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method |
| 01/22/1997 | EP0754228A1 $g(a)-1-ANTICHYMOTRYPSIN ANALOGUES HAVING ELASTASE INHIBITORY ACTIVITY |
| 01/22/1997 | EP0754227A1 Chimeric complement inhibitor proteins |
| 01/22/1997 | EP0754225A1 Transgenic non-human animals capable of producing heterologous antibodies |
| 01/22/1997 | EP0754195A1 Btf2 complex proteins and uses thereof |
| 01/22/1997 | EP0754191A1 Novel receptor-type phosphotyrosine phosphatase-kappa |
| 01/22/1997 | EP0754059A1 Methods and compositions useful for inhibition of angiogenesis |
| 01/22/1997 | EP0754058A1 Wound healing |
| 01/22/1997 | EP0754056A1 Soft agar penetration-defective mutants |
| 01/22/1997 | EP0754050A1 Anti-gram-positive bacterial methods and materials |
| 01/22/1997 | EP0754049A1 Anti-fungal methods and materials |
| 01/22/1997 | EP0559871B1 Method for an in vitro diagnosis of allergies and other inflammatory diseases |
| 01/22/1997 | EP0549581B1 Framework mutated antibodies and their preparation |
| 01/22/1997 | EP0502107B1 Type-b rotavirus cultures and uses thereof |
| 01/22/1997 | EP0500659B1 Monoclonal antibodies |
| 01/22/1997 | EP0461200B1 Modified forms of reproductive hormones |
| 01/22/1997 | CN1141061A Thrombopoietin |
| 01/22/1997 | CN1141060A Haemophilus transferrin receptor genes |
| 01/22/1997 | CN1140999A Anti-fungal methods and materials |
| 01/22/1997 | CN1033866C Recombinant DNA-derived Bordetella toxin subunit analogs |
| 01/22/1997 | CN1033839C Processing method for binding-inducing composition |
| 01/21/1997 | US5596081 Antibodies and atp or gtp |
| 01/21/1997 | US5595904 Family of map2 protein kinases |
| 01/21/1997 | US5595903 Expression vectors, host cells |
| 01/21/1997 | US5595901 Method for obtaining protective active and inactive adenylate cyclase from Bordetella parapertussis |
| 01/21/1997 | US5595895 Efficient directional genetic cloning system |
| 01/21/1997 | US5595889 Process for integration of a chosen gene on the chromosome of a bacterium using Mu transposons |
| 01/21/1997 | US5595888 Recombinant methods of making gamma interferon compositions |
| 01/21/1997 | US5595887 Purification directed cloning of peptides using carbonic anhydrase as the affinity binding segment |
| 01/21/1997 | US5595886 Gene expression in eukaryotic cell, treatment of hemophilia |
| 01/21/1997 | US5595885 Matrix metalloproteinase inhibitor peptides |
| 01/21/1997 | US5595884 Papillomavirus E2 transactivation repressor proteins and DNA |
| 01/21/1997 | US5595869 Diagnostic methods for detecting lymphomas in humans |
| 01/21/1997 | US5595868 Monoclonal antibodies to hepatitis C virus |
| 01/21/1997 | US5595739 Hepatitis B virus mutants, reagents and methods for detection |
| 01/21/1997 | US5595721 Using antibodies directed to an antigen and radioactive labels |
| 01/21/1997 | CA2097821C Ganoderma lucidum iy009 which produces proteoglycan(g009) having effect of enhancing antitumor immunity |
| 01/21/1997 | CA2069086C Stationary storage enclosure with a horizontal axis for compact discs |
| 01/16/1997 | WO1997001642A1 Modified proteins and methods of their production |
| 01/16/1997 | WO1997001640A2 Vaccines against hepatitis c |
| 01/16/1997 | WO1997001638A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | WO1997001636A2 Recombinant mistletoe lectin |
| 01/16/1997 | WO1997001633A1 Cytokine that induces apoptosis |
| 01/16/1997 | WO1997001630A1 HUMAN GLANDULAR KALLIKREIN-1 (hK2) |
| 01/16/1997 | WO1997001577A1 Ion channel |
| 01/16/1997 | WO1997001575A1 Substance wf16616, process for production thereof, and use thereof |
| 01/16/1997 | WO1997001571A1 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 01/16/1997 | WO1997001354A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | DE19607100A1 Neues Verfahren zur Herstellung von Peptiden und N-Carbamoyl-geschützten Peptiden New process for the production of peptides and N-Carbamoyl-protected peptides |
| 01/16/1997 | CA2225405A1 Omp26 antigen from haemophilus influenzae |
| 01/16/1997 | CA2224319A1 Human glandular kallikrein-1 (hk2) |
| 01/16/1997 | CA2222456A1 Vaccines against hepatitis c |
| 01/16/1997 | CA2222024A1 Il-8 antagonists for treatment of inflammatory disorders and asthma |
| 01/16/1997 | CA2221294A1 Tetradotoxin insensitive sodium channel |
| 01/15/1997 | EP0753574A1 Methods and compositions for obtaining ex vivo human progenitor cell expansion |
| 01/15/1997 | EP0753152A1 Solid phase immunoassay to detect inhibitors of proteolytic enzymes |
| 01/15/1997 | EP0753073A1 Heat-inducible n-degron module |
| 01/15/1997 | EP0753071A1 Cell-targeted lytic pore-forming agents |
| 01/15/1997 | EP0753068A1 Ligands added to adenovirus fiber |
| 01/15/1997 | EP0753067A1 RECOMBINANT ADENOVIRUSES CODING FOR BASIC FIBROBLAST GROWTH FACTORS (bFGF) |
| 01/15/1997 | EP0753065A1 Antibodies against e-selectin |
| 01/15/1997 | EP0753064A1 Method for the permanent expression of glutamate receptors |
| 01/15/1997 | EP0753060A1 Conserved t-cell receptor sequences |
| 01/15/1997 | EP0753059A1 Peptide production as fusion protein in transgenic mammal milk |
| 01/15/1997 | EP0753054A1 Expansins, proteins that catalyze plant cell wall expansion and weakening of paper fiber connections |
| 01/15/1997 | EP0753015A1 Monoclonal antibodies recognizing tie-receptor and their use |
| 01/15/1997 | EP0753014A1 IgM-SPECIFIC RECOMBINANT RHEUMATOID ARTHRITIS ANTIGEN |
| 01/15/1997 | EP0753007A1 Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same |
| 01/15/1997 | EP0753006A1 Vpr AND Vpx PROTEINS OF HIV |
| 01/15/1997 | EP0752888A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| 01/15/1997 | EP0752881A1 A novel brain endothelial cell protein and methods for its use |
| 01/15/1997 | EP0752878A1 Products comprising substrates capable of enzymatic cross-linking |
| 01/15/1997 | EP0752876A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 01/15/1997 | EP0752872A1 Nadh oxidase as a target in diagnosis and therapy |
| 01/15/1997 | EP0752853A1 Human brain phosphodiesterase |
| 01/15/1997 | EP0752844A1 Human osteoclast-derived cathepsin |
| 01/15/1997 | EP0736106A4 Methods of screening for beta-amyloid peptide production inhibitors |
| 01/15/1997 | EP0668725B1 Method of preparing protein hydrolysates low in chromium |
| 01/15/1997 | EP0593757B1 Method for obtaining polypeptides in a cell-free system |
| 01/15/1997 | EP0527753B1 Purification and use of pertactin, a bordetella pertussis outer membrane protein |
| 01/15/1997 | CN1140456A Superagonists and antagonists of H IL-6, and 3-D modelling method for their selection |
| 01/15/1997 | CN1140413A Humanized antibodies against leukocyte adhesion molecule VLA-4 |
| 01/15/1997 | CN1033810C Process for enzymatic preparation of basic fibroblast growth factor |
| 01/14/1997 | US5594119 Gene encoding carboxypeptidase of aspergillus niger |